Haku

Docetaxel as neo-adjuvant therapy for radically treatable stage III non-small cell lung cancer : early results of an international phase III study

QR-koodi
Finna-arvio

Docetaxel as neo-adjuvant therapy for radically treatable stage III non-small cell lung cancer : early results of an international phase III study

Tallennettuna: